Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation Read More »
Auto Added by WPeMatico
Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation Read More »
Natural raises $30M to reinvent payments for AI agents — and take on Stripe Read More »
Databricks hits $188B valuation, extending its run as AI’s favorite second act Read More »
Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation Read More »
AI-powered travel agency Fora hits unicorn status, raises $60M Read More »